DEF 14A PROXY STATEMENT

Company

TANDEM DIABETES CARE INC

Filed

April 15, 2020

Period of Report

March 31, 2020

Accession Number

0001438133-20-000032

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →